Back
ConocoPhillips 10K Form
Buy
67
COP
ConocoPhillips
Last Price:
127.35
Seasonality Move:
5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-11-03 | 10Q | COP/ConocoPhillips Quarterly |
2020-08-04 | 10Q | COP/ConocoPhillips Quarterly |
2020-05-05 | 10Q | COP/ConocoPhillips Quarterly |
2020-02-18 | 10K | COP/ConocoPhillips Annual |
2019-10-31 | 10Q | COP/ConocoPhillips Quarterly |
2019-08-01 | 10Q | COP/ConocoPhillips Quarterly |
Receive COP News And Ratings
See the #1 stock for the next 7 days that we like better than COP
COP Financial Statistics
Sales & Book Value
Annual Sales: | $56.14B |
---|---|
Cash Flow: | $2.38B |
Price / Cash Flow: | 17.55 |
Annual Sales: | $41.83 |
Price / Book: | 3.03 |
Profitability
EPS (TTM): | 9.06000 |
---|---|
Net Income (TTM): | $10.96B |
Gross Margin: | $18.2B |
Return on Equity: | 22.8% |
Return on Assets: | 11.8% |
ConocoPhillips Earnings Forecast
Key ConocoPhillips Financial Ratios
- The Gross Profit Margin over the past 40 years for COP is 32.42%.
- The Selling, General & Administrative Expenses for COP have been equal to 1.26% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 9.70% of Operating Income.
- The Net Earning history of COP is 19.52% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 21 years.
ConocoPhillips Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Oil & Gas E&P |
Sector: | Energy |
Current Symbol: | COP |
CUSIP: | 20825C |
Website: | conocophillips.com |
Debt
Debt-to-Equity Ratio: | 0.38 |
---|---|
Current Ratio: | 1.43 |
Quick Ratio: | 1.21 |
Price-to-Earnings
Trailing P/E Ratio: | 14 |
---|---|
Forward P/E Ratio: | 13.01 |
COP Technical Analysis vs Fundamental Analysis
Buy
67
ConocoPhillips (COP)
is a Buy
Is ConocoPhillips a Buy or a Sell?
-
ConocoPhillips stock is rated a Buy
The current ConocoPhillips [COP] share price is $126.84. The Score for COP is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.